Search results

...It is a form of the cancer drug cytarabine that may work in patients with leukemia who are resistant to cytarabine.  ...It is a form of the cancer drug cytarabine that may work in patients with leukemia who are resistant to cytarabine. CP-4055 blocks cell division and can kill

...It is a form of the cancer drug cytarabine that may work in patients with leukemia who are resistant to cytarabine.  ...It is a form of the cancer drug cytarabine that may work in patients with leukemia who are resistant to cytarabine. Elacyt blocks cell division and can kill c

...It is a form of the cancer drug cytarabine that may work in patients with leukemia who are resistant to cytarabine.  ...It is a form of the cancer drug cytarabine that may work in patients with leukemia who are resistant to cytarabine. Elacytarabine blocks cell division and can

== Leukemia Cutis == ...involvement by [[leukemia]], typically observed in patients with systemic leukemia.

...prolymphocytic leukemia''' ('''TPCL''') is a rare and aggressive type of [[leukemia]] that affects the [[T cells]] of the [[immune system]]. T-cell prolymphocytic leukemia is pronounced as "tee-sell proh-lim-foh-sy-tik loo-kee-mee-uh".

...icine used with other medicines to treat acute myeloid leukemia in adults, advanced prostate cancer that does not improve with hormone therapy, and certain for ...icine used with other medicines to treat acute myeloid leukemia in adults, advanced prostate cancer that does not improve with hormone therapy, and certain for

...the study of [[Thalassemia]] and [[Leukemia]]. His work has significantly advanced the understanding and treatment of these conditions. * [[Leukemia]]: A group of cancers that usually begins in the bone marrow and results in

...mutation (change) in the RETG gene. It is used in patients whose cancer is advanced or has spread to other parts of the body.  ..., which is found on B cells (a type of white blood cell) and some types of leukemia and lymphoma cells. Gazyva can block CD20 and help the immune system kill c

...s and was the first combination chemotherapy regimen that was able to cure advanced stage Hodgkin's disease. MOPP is used in the treatment of both early-stage and advanced-stage [[Hodgkin's disease]]. The regimen is typically administered in cycle

Rucaparib is used in the treatment of advanced ovarian cancer that has been treated with two or more chemotherapies and co ...e serious side effects can include myelodysplastic syndrome, acute myeloid leukemia, and pneumonitis.

* They are often able to provide more advanced and targeted treatment options, and their expertise can be crucial in diagn ...eatment of disorders of the blood, including conditions such as anemia and leukemia.